The FDA has scheduled an Oct. 15 meeting of its advisory committee to discuss whether to grant authorization for a booster dose of the J&J vaccine.
Related Articles
-
England to enter strictest lockdown since March as new variant drives spiraling Covid crisis
LONDON — British Prime Minister Boris Johnson on Monday announced a new national lockdown in England, including the most...
-
Covid disease damage leading to ‘completely new category’ of organ transplants
In a year when Covid-19 shattered the pleas of so many who prayed for miracles, a Georgia man with...
-
The U.S. hasn’t OK’d boosters for those who got the J&J vaccine. But some are getting one anyway.
In early April, Mark Dinan got the single-dose Johnson & Johnson vaccine at a middle school campus near his...
-
U.K.’s first non-white leader? Finance minister Sunak wins praise for staying calm in a crisis
LONDON — It’s been a tough year for front-line politicians in Britain. Few have impressed as the country battles...
-
No major organized religion objects to Covid vaccines. Will religious exemptions hold?
Religious exemptions could prove to be the latest legal battlefield of the pandemic, as Americans opposed to the coronavirus...
-
Pfizer and Moderna vaccines 90 percent effective in ‘real-world’ study, CDC says
The Pfizer and Moderna Covid-19 vaccines are extremely effective in the real world, reducing infections by 90 percent in...
-
Risk of breakthrough infections remains very rare, 3 studies find
The Covid-19 vaccines continue to offer strong protection against severe illness and hospitalization, according to research on more than...
-
4 million dead: Covid has killed as many people as live in LA
The official global Covid-19 death toll has topped 4 million, about equal to the population of Los Angeles, according...
Recent Comments